Claudia Regina Bonini-Domingos

Claudia Regina Bonini-Domingos

Auto-generated profile, based on publicly available information

Claudia Regina Bonini-Domingos

Universidade Estadual Paulista, Brasil

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
CCCarlos Eugênio Cavasini
Carlos Eugênio Cavasini
LMLuiz Carlos De Mattos
Luiz Carlos De Mattos
ÁCÁlvaro Augusto D’aLmeida Couto
Álvaro Augusto D’aLmeida Couto
CBCláudia Regina Bonini-Domingos
Cláudia Regina Bonini-Domingos
SVSocrates Herrera Valencia
Socrates Herrera Valencia
RMRicardo Luiz Machado
Ricardo Luiz Machado
We present evidence for Plasmodium vivax infection among Duffy blood group-negative inhabitants of Brazil. The P. vivax identification was determined by both genotypic and non-genotypic screening tests. The Duffy blood group was genotyped by PCR/RFLP and phenotyped using a microtyping kit. We detected two homozygous FY*B-33 carriers infected by P. vivax, whose circumsporozoite protein genotypes were VK210 and/or P. vivax-like. Additional efforts are necessary in order to clarify the evidence that P. vivax is being transmitted among Duffy blood group-negative patients from the Brazilian Amazon region.

1 December 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DSDanilo Grünig Humberto da Silva
Danilo Grünig Humberto da Silva
EJEdis Belini Junior
Edis Belini Junior
EAEduardo Alves de Almeida
Eduardo Alves de Almeida
CBClaudia Regina Bonini-Domingos
Claudia Regina Bonini-Domingos

19 December 2007 in Malaria Journal
Verified
Journal Article
Open access
PDF file
CCCarlos E Cavasini
Carlos E Cavasini
LMLuiz Carlos De Mattos
Luiz Carlos De Mattos
ÁCÁlvaro Ar D'ALmeida Couto
Álvaro Ar D'ALmeida Couto
VCVanja Sc D'ALmeida Couto
Vanja Sc D'ALmeida Couto
YGYuri Gollino
Yuri Gollino
RMRicardo Luiz Machado
Ricardo Luiz Machado
Duffy blood group polymorphisms are important in areas where Plasmodium vivax predominates, because this molecule acts as a receptor for this protozoan. In the present study, Duffy blood group genotyping in P. vivax malaria patients from four different Brazilian endemic areas is reported, exploring significant associations between blood group variants and susceptibility or resistance to malaria.

1 June 2011 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
DSDanilo Grünig Humberto da Silva
Danilo Grünig Humberto da Silva
EJEdis Belini Junior
Edis Belini Junior
Lidiane S TorresLidiane S Torres
Lidiane S Torres
OJOctávio Ricci Júnior
Octávio Ricci Júnior
CLClarisse de Castro Lobo
Clarisse de Castro Lobo
EAEduardo Alves de Almeida
Eduardo Alves de Almeida

1 January 2012 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
Lidiane S TorresLidiane S Torres
Lidiane S Torres
DSDanilo Grünig Humberto da Silva
Danilo Grünig Humberto da Silva
EJEdis Belini Junior
Edis Belini Junior
EAEduardo Alves de Almeida
Eduardo Alves de Almeida
CLClarisse Lopes de Castro Lobo
Clarisse Lopes de Castro Lobo
CBClaudia Regina Bonini-Domingos
Claudia Regina Bonini-Domingos
The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). On the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.

9 October 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
DSDanilo Grünig Humberto da Silva
Danilo Grünig Humberto da Silva
EJEdis Belini Junior
Edis Belini Junior
GCGisele Cristine de Souza Carrocini
Gisele Cristine de Souza Carrocini
Lidiane S TorresLidiane S Torres
Lidiane S Torres
OJOctávio Ricci Júnior
Octávio Ricci Júnior
EAEduardo Alves de Almeida
Eduardo Alves de Almeida
Background: Sickle cell anemia (SCA) presents a complex pathophysiology which can be affected by a number of modifying factors, including genetic and biochemical ones. In Brazil, there have been no studies verifying βS-haplotypes effect on oxidative stress parameters. This study evaluated βS-haplotypes and Hb F levels effects on oxidative stress markers and their relationship with hydroxyurea (HU) treatment in SCA patients.Methods: The studied group was composed by 28 SCA patients. Thirteen of these patients were treated with HU and 15 of them were not. We used molecular methodology (PCR-RFLP) for hemoglobin S genotype confirmation and haplotypes identification. Biochemical parameters were measured using spectrophotometric methods (Thiobarbituric-acid-reactive substances and Trolox equivalent antioxidant capacity levels, catalase and GST activities) and plasma glutathione levels by High-performance liquid chromatography coupled to electrochemical detection.Results: We found the highest frequency of Bantu haplotype (48.2%) which was followed by Benin (32.1%). We observed also the presence of Cameroon haplotype, rare in Brazilian population and 19.7% of atypical haplotypes. The protective Hb F effect was confirmed in SCA patients because these patients showed an increase in Hb F levels that resulted in a 41.3% decrease on the lipid peroxidation levels (r =−0.74, p=0.01). Other biochemical parameters have not shown differential expression according to patient’s haplotypes. Bantu haplotype presence was related to the highest lipid peroxidation levels in patients (p < 0,01), but it also conferred a differential response to HU treatment, raising Hb F levels in 52.6% (p = 0.03) when compared with the group with the same molecular profile without HU usage.Conclusions: SCA patients with Bantu haplotype showed the worst oxidative status. However these patients also demonstrated a better response to the treatment with HU. Such treatment seems to have presented a “haplotype-dependent” pharmacological effect.